by Maria Zannes | Jan 30, 2024 | Press Releases
SAN ANTONIO, Texas (Jan. 30, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, provides a summary of recent Company news. Precision...
by Maria Zannes | Jan 23, 2024 | Press Releases
Indian Patent Office Grants Patent Related to Porphyrin Compounds for Targeted Cancer Treatment SAN ANTONIO, Texas (Jan. 23, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for...
by Maria Zannes | Jan 8, 2024 | Press Releases
SAN ANTONIO, Texas (Jan. 8, 2024) – Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease....
by Maria Zannes | Dec 5, 2023 | Press Releases
SAN ANTONIO, Texas (Dec. 5, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie Platt,...
by Maria Zannes | Nov 30, 2023 | Press Releases
SAN ANTONIO, Texas (Nov. 30, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other lung diseases, today announced that the Centers for Medicare and...
